S. Poucher, J. Keddie, R. Brooks
Jun 1, 1996
Citations
0
Influential Citations
41
Citations
Journal
Journal of Pharmacy and Pharmacology
Abstract
4‐(2‐[7‐Amino‐2‐(2‐furyl)[1,2,4]triazolo[2,3‐a][1,3,5]triazin‐5‐ylamino]ethyl)phenol (ZM 241385) is currently the most selective for the A2a adenosine receptor antagonist. This paper describes the in‐vivo activity of ZM 241385 after administration by both oral and intraduodenal routes.